This medication benefits T2DM patients through different mechanisms, such as increasing insulin excretion, delaying gastric emptying, inhibiting glucagon production, and decreasing pancreatic beta cell apoptosis [37]. This evidence concerns the gene GCG and type 2 diabetes mellitus.